I'm all for it but why hasn't it happened yet? $6 to $1.40 in 1 year. Something is wrong. How come nobody but us retail investors see it?
I've always believed the valuation to be on the order of $10-$12 when compared to peers with much much less to offer. We are the red headed step child of pharma no thanks to Jack Lief. Look at ACAD and their patents, their pipeline, and their FDA approved product (ooops, they don't have one) and tell me I'm wrong.
The problem is those other stocks realized all time highs 6 months ago and have a buffer. Arena continued its downward course over 3 years and now is at all time lows at $1.40 with $0.00 around the corner. We need news. We need insider buys. We need a miracle.
Stay the course with 10 thumbs up... We're at $1.50 man. Worse than pre AdCom 1 and worse than pre AdCom 2 but with a lot more shares.
Stay the course would mean Arna at 75 cents per share with 500 million shares and no hope for the future.
Price is 70 cents man. Bottom line it sucks. Your interpretation of the data is clearly wrong. 70 cents man! Yeah I am long but your babble is beyond ridiculous. Wake me when Gale is $20.
Come on Hixson. Say something. Do something. We're dying here.
Gale shares are extremely hard to borrow. As a result, these HFs struck a deal with GALE, creating 20 million shares out of the blue. Incidentally, the same HF allowed itself to short against that position for an additional 50% gain. As you can see, HFs rarely lose. Too bad execs at Galena gave in before the big news. HFS would have been cooked.
Wrong. That percentage includes short positions being covered. Stop trying to fool people.
Ralinepag is superior to selexipag both in potency and efficacy for these secondary cellular signals (cAMP levels).
Arena developed RVT-101. Oooops! If approved for market Arena gets a handsome perxentage in royalties.
Unbelievable corruption with these bios. 67 million shorts down to 19 million and price falls from $12 to $1.50. Something is fishy here no doubt.
I continue to hold for the Powerball payout.
I've never seen short interest so low. When ARNA turns it will rocket to $12 in a flash. That time, all HFs will have covered and switched long.
Look at market cap of AXON which uses an ARNA developed drug as their lead research candidate. Yup. AXON with no product, no pipeline, no research and development has a market cap of $1.6B.
ARNA at $350M? Gimme a break people. We should be sitting at $10 not $1.50.
More bull. 50% drop in 1 week my friend. Who cares if it traded less than 10% of float. It was $2.60! Now $1.30. And you feel good that less than 10% of float traded? So foolish.